The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 75-83

  D'Agostino, Donna M ^a   Ciminale, Vincenzo ^a   Zotti, Lorenza ^a   Rosato, Antonio ^a   Chieco Bianchi, Luigi ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; NUCLEAR PROTEIN; REGULATOR PROTEIN;

ARTICLE; CELLULAR DISTRIBUTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TARGETING; VIRUS REPLICATION;

EID: 0031060199     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.75-83.1997     Document Type: Article

References (63)

1. Benko, D. M., R. Robinson, L. Solomin, M. Mellini, B. K. Felber, and G. N. Pavlakis. 1991. Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting rev-responsive element does not affect the fate of viral mRNA. New Biol. 2:1111-1122.
2. Berneman, Z. N., R. B. Gartenhaus, M. S. Reitz, W. A. Blattner, A. Manns, B. Hanchard, O. Ikehara, R. C. Gallo, and M. E. Klotman. 1992. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc. Natl. Acad. Sci. USA 89:3005-3009.
3. Bhat, N. K., Y. Adachi, K. P. Samuel, and D. Derse. 1993. HTLV-I gene expression by defective proviruses in an infected T-cell line. Virology 196:15-24.
4. Bogerd, H. P., G. L. Huckaby, Y. F. Ahmed, S. M. Hanly, and W. C. Greene. 1991. The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc. Natl. Acad. Sci. USA 88:5704-5708.
5. Bogerd, H. P., and W. C. Greene. 1993. Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo. J. Virol. 67:2496-2502.
6. Cann, A. J., and I. S. Y. Chen. 1996. Human T-cell leukemia virus types I and II. p. 1849-1880. In B. N. Fields, D. M. Knipe, P. M. Howley et al. (ed.), Fields virology, 3rd ed. Raven Press. Ltd., New York, N.Y.
7. Caputo, A., and W. A. Haseltine. 1992. Reexamination of the coding potential of the HTLV-I pX region. Virology 188:618-627.
8. Ciminale, V., G. N. Pavlakis, D. Derse, C. P. Cunningham, and B. K. Felber. 1992. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV-1. J. Virol. 66:1737-1745.
9. Ciminale, V., D. M. D'Agostino, L. Zotti, G. Franchini, B. K. Felber, and L. Chieco-Bianchi. 1995. Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology 209:445-456.
10. Cochrane, A. W., S. Jones, S. Beidas, P. J. Dillon, A. M. Skalka, and C. A. Rosen. 1991. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65:5305-5313.
11. Cullen, B. R., J. Hauber, K. Campbell, J. G. Sodroski, W. A. Haseltine, and C. A. Rosen. 1988. Subcellular localization of the human immunodeficiency virus trans-acting art gene product. J. Virol. 62:2498-2501.
12. D'Agostino, D. M., V. Ciminale, G. N. Pavlakis, and L. Chieco-Bianchi. 1995. Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: involvement of continued rRNA synthesis in nuclear retention. AIDS Res. Hum. Retroviruses 11:1063-1071.
13. Derse, D., J. Mikovits, M. Polianova, B. K. Felber, and F. Ruscetti. 1995. Virions released from cells transacted with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells. J. Virol. 69:1907-1912.
14. Dingwall, C., and R. A. Laskey. 1991. Nuclear targeting sequences - a consensus? Trends Biochem. Sci. 16:478-481.
15. + ATPase. J. Virol. 67:7701-7704.
16. Franchini, G. 1995. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86:3619-3639.
17. 16a.Franchini, G. Personal communication.
18. Fuller, S. A., M. Takahashi, and J. G. R. Hurrell. 1995. Immunization of mice, p. 11.4.2-11.4.5. In F. M. Ausubel et al. (ed.), Current protocols in molecular biology, vol. 2. John Wiley & Sons, New York, N.Y.
19. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
20. Gitlin, S. D., J. Dittmer, R. L. Reid, and J. N. Brady. 1993. The molecular biology of human T-cell leukemia viruses, p. 159-192. In B. R. Cullen (ed.), Human retroviruses. Oxford University Press, New York, N.Y.
21. Graham, F. J., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-460.
22. Hidaka, M., J. Inoue, M. Yoshida, and M. Seiki. 1988. Posttranscriptional regulator (rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 7:519-523.
23. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. I. Kinoshita, S. Shirakawa, and I. Miyoshi. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78:6476-6480.
24. Hope, T. J., B. L. Bond, D. McDonald, N. P. Klein, and T. G. Parslow. 1991. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J. Virol. 65:6001-6007.
25. Kalland, K.-H., A. M. Szilvay, K. A. Brokstad, W. Saetrevik, and G. Haukenes. 1994. The human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear components. Mol. Cell. Biol. 14:7436-7444.
26. Katahira, J., T. Ishizaki, H. Sakai, A. Adachi, K. Yamamoto, and H. Shida. 1995. Effects of translation initiation factor eLF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding. J. Virol. 69:3125-3133.
27. Kiyokawa, T., M. Seiki, S. Iwashita, K. Imagawa, F. Shimizu, and M. Yoshida. 1985. p27XIII and p21XIII proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 82:8359-8363.
28. Koralnik, I. J., A. Gessain, M. E. Klotman, A. Lo Monico, Z. N. Berneman, and G. Franchini. 1992. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc. Natl. Acad. Sci. USA 89:8813-8817.
29. II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames are localized in three different cellular compartments. J. Virol. 67:2360-2366.
30. x protein. Virology 220:502-507.
31. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
32. Luciw, P. A. 1996. Human immunodeficiency viruses and their replication, p. 1881-1951. In B. N. Fields, D. M. Knipe, P. M. Howley et al. (ed.), Fields virology, 3rd ed. Raven Press, Ltd., New York, N.Y.
33. Maldarelli, F., M. A. Martin, and K. Strebel. 1991. Identification of post-transcriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65:5732-5743.
34. Melchior, F., and L. Gerace. 1995. Mechanisms of nuclear protein import. Curr. Opin. Cell Biol. 7:310-318.
35. Mermer, B., B. K. Felber, M. Campbell, and G. N. Pavlakis. 1990. Identification of trans-dominant HIV-1 protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res. 18:2037-2044.
36. Meyer, B. E., and M. H. Malim. 1994. The HIV-1 Rev transactivator shuttles between the nucleus and the cytoplasm. Genes Dev. 8:1538-1547.
37. x and two other phosphoproteins. J. Virol. 60:394-399.
38. Nosaka, T., H. Siomi, Y. Adachi, M. Ishibashi, S. Kubota, M. Maki, and M. Hatanaka. 1989. Nucleolar targeting signal of human T-cell leukemia virus type I rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA. Proc. Natl. Acad. Sci. USA 86:9798-9802.
39. Nosaka, T., Y. Miyazaki, T. Takamatsu, K. Sano, M. Nakai, S. Fujita, T. E. Martin, and M. Hatanaka. 1995. The post-transcriptional regulator Rex of the human T-cell leukemia virus type I is present as nucleolar speckles in infected cells. Exp. Cell Res. 219:122-129.
40. Orita, S., A. Saiga, S. Takagi, T. Takanka, K. Okumura, Y. Aono, Y. Hinuma, and H. Igarashi. 1991. A novel alternatively spliced viral mRNA transcribed in cells infected with human T-cell leukemia virus type 1 is mainly responsible for expressing p21X protein. FEBS Lett. 295:127-134.
41. Osame, M., K. Usuku, S. Izumo, N. Ijuchi, H. Amitani, A. Agata, M. Matsumoto, and M. Tara. 1986. HTLV-I-associated myelopathy, a new clinical entity. Lancet i:1031-1032.
42. Parslow, T. G. 1993. Post-transcriptional regulation of human retroviral gene expression, p. 101-136. In B. R. Cullen (ed.), Human retroviruses. Oxford University Press, New York, N.Y.
43. Perry, R. P., and D. E. Kelley. 1970. Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species. J. Cell Physiol. 76:127-140.
44. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
45. Prasher, D. C., V. K. Eckenrode, W. W. Ward, F. G. Prendgast, and M. J. Cormier. 1992. Primary structure of the Aequorea victoria green-fluorescent protein. Gene 111:229-233.
46. Richard, N., S. Iacampo, and A. Cochrane. 1994. HIV-1 Rev is capable of shuttling between the nucleus and the cytoplasm. Virology 204:123-131.
47. Rizzuto, R., M. Brini, P. Pizzo, M. Murgia, and T. Pozzan. 1995. Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells. Curr. Biol. 5:635-642.
48. Robbins, J., S. M. Dilworth, R. A. Laskey, and C. Dingwall. 1991. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64:615-623.
49. rex, or envelope expression. J. Virol. 68:3448-3451.
50. Ruben, S., A. Perkins, R. Purcell, K. Joung, R. Sia, R. Burghoff, W. A. Haseltine, and C. A. Rosen. 1989. Structural and functional characterization of human immunodeficiency virus tat protein. J. Virol. 63:1-8.
51. Schwartz, S., B. K. Felber, D. M. Benko, E. M. Fenyö, and G. N. Pavlakis. 1990. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64:2519-2529.
52. Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1992. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev. J. Virol. 66:150-159.
53. Seiki, M., Y. Hattori, and M. Yoshida. 1982. Human adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure. Proc. Natl. Acad. Sci. USA 79:6899-6902.
54. Silver, P. A. 1991. How proteins enter the nucleus. Cell 64:489-497.
55. Siomi, H., H. Shida, S. H. Nam, T. Nosaka, M. Maki, and M. Hatanaka. 1988. Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell 55:197-209.
56. Siomi, H., H. Shida, M. Makai, and M. Hatanaka. 1990. Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J. Virol. 64:1803-1807.
57. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione-S-transferase. Gene 67:31-40.
58. Smith, D. B., and L. M. Corcoran. 1994. Expression and purification of glutathione-S-transferase fusion proteins, p. 16.7.1-16.7.7. In F. M. Ausubel et al. (ed.), Current protocols in molecular biology, vol. 2. John Wiley & Sons, New York, N.Y.
59. Solomin, L., B. K. Felber, and G. N. Pavlakis. 1990. Different sites of interaction for Rev, Tev, and Rex proteins within the rev-responsive element of human immunodeficiency virus type 1. J. Virol. 64:6010-6017.
60. Stauber, R., G. A. Gaitanaris, and G. N. Pavlakis. 1995. Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions: transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm. Virology 213:439-449.
61. Weichselbraun, I., J. Berger, M. Dobrovnik, H. Bogerd, R. Grassman, W. C. Greene, J. Hauber, and E. Bohnlein. 1992. Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance. J. Virol. 66:4540-4545.
62. Wright, C. M., B. K. Felber, H. Paskalis, and G. N. Pavlakis. 1986. Expression and characterization of the trans-activator of HTLV-III/LAV virus. Science 234:988-992.
63. Zazopoulos, E., J. G. Sodroski, and W. A. Haseltine. 1990. p21rex protein of HTLV-I. J. Acquired Immune Defic. Syndr. 3:1135-1139.